Original post published by Amy Hung (Global co-leader, McKinsey HealthTech Network) on November 10, 2021
Amy Hung interviews Naomi Fried, Ph.D., Founder and CEO of PharmStars, a pharma-focused accelerator for digital health startups, dedicated to driving digital health adoption to improve patient outcomes. They educate and mentor startups seeking engagement with pharma and biotech companies. Naomi talks about the pharma-startup gap and what led her to want to play a role to bridge that gap and bring about more healthtech startup and pharma collaborations to drive forward innovation.
PharmStars™ is the first and only non-proprietary pharma-focused accelerator for digital health startups. Through our extensive expertise across pharma, startups, digital health, and innovation, we understand the challenges that pharma and startups face when seeking to collaborate. Our PharmaU™ program supports digital health startups and our pharma members in "bridging the gap," leading to greater success and faster adoption of "beyond the molecule" solutions for patients. www.PharmStars.com